Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Alkindi
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Alkindi 2mg granules in capsules for opening
0603020J0BFACCZ
|
Alkindi | Hydrocortisone | Endocrine System | 478 |
|
Alkindi 1mg granules in capsules for opening
0603020J0BFABCY
|
Alkindi | Hydrocortisone | Endocrine System | 441 |
|
Alkindi 0.5mg granules in capsules for opening
0603020J0BFAACX
|
Alkindi | Hydrocortisone | Endocrine System | 291 |
|
Alkindi 5mg granules in capsules for opening
0603020J0BFADDA
|
Alkindi | Hydrocortisone | Endocrine System | 169 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.